Since c-MYC was unveiled as a protein partner of PRR11 (Figure 4B) and c-MYC gene was shown to undergo melanoma-specific intron retention (Figure 1), all five intronic miRNA target genes and some additional ones encoding selected protein interactors were, next, examined for intron retention incidents. The gene discussed is PRR11; the disease is melanoma.